1. Home
  2. BOLT vs AUUD Comparison

BOLT vs AUUD Comparison

Compare BOLT & AUUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

N/A

Current Price

$3.35

Market Cap

7.1M

Sector

Health Care

ML Signal

N/A

Logo Auddia Inc.

AUUD

Auddia Inc.

N/A

Current Price

$1.04

Market Cap

5.8M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
BOLT
AUUD
Founded
2015
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
5.8M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
BOLT
AUUD
Price
$3.35
$1.04
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$34.00
N/A
AVG Volume (30 Days)
22.2K
370.0K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,695,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$133.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.07
N/A
52 Week Low
$3.13
$0.51
52 Week High
$7.20
$10.10

Technical Indicators

Market Signals
Indicator
BOLT
AUUD
Relative Strength Index (RSI) 56.19 45.25
Support Level $3.87 $0.91
Resistance Level $4.33 $1.08
Average True Range (ATR) 0.31 0.05
MACD 0.03 0.01
Stochastic Oscillator 70.27 53.05

Price Performance

Historical Comparison
BOLT
AUUD

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.

About AUUD Auddia Inc.

Auddia Inc is a United States-based company. It operates through its proprietary AI platform for audio and is reinventing not only how consumers engage with AM/FM radio, podcasts, and other audio content but also how artists and labels promote their music and gain access to mainstream radio audiences. The group Discovr Radio is the first music-promotion platform to deliver artists guaranteed exposure to radio listeners. Its flagship audio superapp, called faidr, delivers multiple industry firsts, including: Ad-free listening on any AM/FM radio station, Content skipping across any AM/FM station, One-touch skipping of entire podcast ad breaks, and Integrated artist discovery experiences.

Share on Social Networks: